|
Geographic Management of Cancer Health Disparities Program (GMaP) Region 1-South
September 02, 2022 Newsletter
|
|
|
GMaP is an integrated network of three regions within the United States. The GMaP R1S hub is based at the UNC Lineberger Comprehensive Cancer Center and in partnership with the Hollings Cancer Center and Vanderbilt-Ingram Cancer Center, serves North Carolina, South Carolina and Tennessee.
|
|
|
You are receiving this newsletter as a Cancer Researcher in GMaP Region 1-South.
|
|
|
|
GMaP Region 1-South
Happy September!
|
|
 |
 |
EIAP Facilitates the Advancement of Scientists from Diverse Backgrounds
The Early Investigator Advancement Program (EIAP)will accept applications from October 1 – November 1, 2022 for its second cohort of EIAP Scholars. We would welcome and appreciate you sharing this news with your grantees and networks.
With the support of the Equity Council, NCI launched EIAP in late 2021 to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. The cancer research enterprise needs a continuous flow of talent through the research career pipeline to thrive. One critical juncture is the transition from junior investigator to independent investigator. Each year, EIAP supports the professional and career development of a cohort of eligible and qualified Early Stage Investigators and New Investigators from institutions across the country. |
|
 |
The EIAP aims to:
- Enhance professional skills;
- Guide preparation of an R01 grant application;
- Provide access to a mentoring and peer network; and
- Grow a community of emerging independent investigators from diverse backgrounds.
EIAP applications must be submitted between October 1 and November 1, 2022. Program staff will hold the EIAP Pre-Application Webinar on October 11, 2022 at 3:00 pm Eastern. Prospective applicants are encouraged to register. The target start date will be March 1, 2023.
Potential applicants should visit the EIAP webpage to learn about the first cohort and access information about eligibility, application instructions, and the pre-application webinar.
NCI values diversity and particularly encourages applicants from populations underrepresented in the biomedical sciences, as noted in the Notice of NIH's Interest in Diversity (NOT-OD-20-031).
Contact: Drs. Samson Gebreab and Maria Jamela (Jay) Revilleza, EIAP@nih.gov
|
|
|
|
News - Events - Conference
Reminder: Stimulus Award Applications Still Rolling
GMaP Region 1-South
Cancer Health Disparities Professional Development and Research Stimulus Awards – Round 3
Researchers from HBCUs and Tribal Colleges/Universities are Strongly Encouraged to Apply
Deadline: Rolling
Funding Amount: Up to $10,000 per award
Access Application
The goal of the GMaP Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards is to facilitate the development of a diverse cadre of cancer researchers from high school to early stage faculty. The Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards are merit awards made to individuals, not institutions, to support a range of cancer research activities, including the purchase of research-related resources (e.g., laboratory research supplies and equipment, transcription fees, data purchase or reuse fees, software, publication fees), research training (e.g., statistical or research methods courses), travel (e.g., presentation at a professional meeting or conference), pilot research study expenses, and other professional development or research-related expenses (e.g., poster printing).
Applications are strongly encouraged from cancer investigators who are underrepresented in the biomedical sciences according to NIH guidelines for underrepresented populations or research trainees conducting cancer disparities research. We welcome applications from any discipline and institution across the Region 1-South region (NC, SC, and TN) with priority given to Historically Black and Tribal Colleges and Universities.
All expenses must be invoiced by November 30, 2022. Available funding per awardee will vary depending on the nature of the request and justification for the funding with two tiers of funding described below.
Tier 1: Up to $5,000 (below is a non-exhaustive set of example expenses appropriate for Tier 1 funding):
- Registration and travel costs for professional meetings or conferences (priority given to applicants presenting research/abstracts at such meetings)
- Registration for training courses and workshops
- Publication costs
- Abstract submission and poster printing costs for professional meetings or conferences
- Biostatistical analyst or research consultant costs
Previous GMaP Region 1-South awardees have used funds to attend annual meetings hosted by the American Association of Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and Advancing the Science of Cancer in Latinos, as well as professional development programs such as the SITC Cytokines in Immunotherapy Workshop and the Statistical Horizons Propensity Score Analysis seminar.
Tier 2: $5,001 - $10,000 (below is a non-exhaustive set of example expenses appropriate for Tier 2 funding):
- Research that generates initial or basic discoveries relevant to cancer regardless of whether the context of the discovery is the laboratory or the field
- Expert consultations with senior researchers
- Support for building and sustaining community advisory boards
- Providing summer mentored-research experience to underrepresented students ranging from high school to undergraduate
- Research consultancy fees to support HBCU and Tribal College/University faculty engaged in research and mentoring
- Non-computer equipment such as software
- Costs associated with the processing/assaying of biospecimens
- Purchase of secondary data or assembly of data/analytic datasets
- Incentives for research participants
- Transcription costs
This article is a useful reference for thinking about planning pilot research.
These merit awards are unique in that they are meant to support professional development of individual promising researchers in a variety of ways. As such, they are not typical research awards and will not be processed through institutional Offices of Sponsored Research. These awards may NOT be used for (1) institutional salary support for post-doctoral or faculty-level applicants, (2) office supplies, durable equipment or computers, (3) meals, or (4) institutional indirect costs. The funds are intended to support individual researchers’ professional development directly and are evaluated based upon individual merits and do NOT permit institutional indirect costs.
This award is open to all developing cancer researchers who are members of GMaP Region 1-South (i.e., high school students, undergraduate students, graduate students, post-docs, early-stage faculty, and faculty mentors from HBCU or Tribal Colleges/Universities) who are underrepresented in the biomedical sciences or studying cancer health disparities. If you are not a member of Region 1-South, you can join by emailing us at gmapregion1s@gmail.com.
All Tier 2 applicants must include a faculty research mentor. The faculty research mentor does not have to be a member of GMaP Region 1-South.
The GMaP Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards will be processed in multiple ways, depending on the scope and nature of individual award requests. All funds must be expended and invoiced by November 30, 2022. GMaP Region 1-South staff will work with funded projects throughout the funding period to monitor progress and provide assistance where necessary. A final report of outcomes will be required. Additionally, GMaP Region 1-South expects awardees to acknowledge the award in any related publications, presentations, or other academic products emerging from the work. A funding disclosure statement will be provided to awardees to use for this purpose.
Applications should be presented in a clear and logical fashion, make a convincing case for the significance of the work or how the funding will stimulate research or development as a research scholar, and describe the proposed use of funds in sufficient detail so that an adequate evaluation of the application can be made. The review committee will be comprised of a diverse community of reviewers who are Cancer Center faculty as well as HBCU or Tribal College/University faculty from the three GMaP Region 1-South regions.
The following review criteria will be considered (not exhaustive given the variety of applications to be considered):
- Significance of the work or potential for the funds to directly advance the applicant’s career development
- Potential to lead to future external funding, publications, or other research products
- Soundness of the proposed methods (if relevant) or appropriateness of career development activities
***Please note: Projects that will require a new, full human subjects IRB application for review will not be considered due to the funding time window. However, projects that will require an IRB modification or be expected to be exempted from full review will be considered.
- Feasibility of accomplishing all stated project goals and expensing funds by November 30, 2022
- Abstract: A summary of the application (200 word maximum).
- Career Impact: Briefly describe the likelihood for your project/funding request to influence your development as a researcher (500 word maximum).
- Research or Career Development Plan (Upload): Research Plans should include Goals, Background, Approach, and Timeline. Career Development Plans should include Goals, Personal Statement, Career Development Activities, and Timeline. Please use double line spacing, font Arial 11 pt., and 1-inch margins all around. (No more than 3 pages allowed, including tables and figures. References do not count towards the page limit and should be appended to the end of the plan, where relevant.)
- Budget Justification (Upload): Include sufficient detail for reviewers to assess the appropriateness for the funding relevant to your research and/or professional development goals.
- NIH Biosketch (Faculty applicants) or Curriculum Vitae/Resume (All non-faculty applicants) (Upload).
- Name(s) and contact information for research mentor(s) (optional for Tier 1, required for Tier 2)
- Name(s) and contact information for applicant’s departmental business manager/administrator (required)
If you have any additional questions about this application process or eligibility, please contact our Regional Coordinating Director Anissa Vines and Administrative Coordinator Erin Laurie by emailing gmapregion1s@gmail.com. You can also reach Dr. Vines directly at avines@email.unc.edu, and Ms. Laurie at erin_laurie@med.unc.edu.
|
|
|
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.
Special Announcements
Upcoming Deadlines for Fogarty Funding Opportunities
Funding Opportunities
NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:
NIH funding opportunities for which foreign components may apply:
- Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) (RFA-CA-22-046)
Application Receipt Date(s): October 03, 2022
- Fostering Mental, Emotional, and Behavioral (MEB) Health Among Children in School Settings: Opportunities for Multisite Trials of Complementary and Integrative Health Interventions (Clinical Trial Optional) (RFA-AT-23-003)
Application Receipt Date(s): October 28, 2022
- Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimer’s Disease/Alzheimer’s Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed) (RFA-NS-22-061)
Application Receipt Date(s): November 4, 2022
- Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional) (RFA-CA-22-031)
Application Receipt Date(s): November 7, 2022
- Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional) (RFA-AT-23-005)
Application Receipt Date(s): November 30, 2022
- MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed) (RFA-HD-23-018)
Application Receipt Date(s): December 1, 2022
- HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed) (RFA-DA-23-050)
Application Receipt Date(s): February 3, 2023
- HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required) (RFA-DA-23-055)
Application Receipt Date(s): February 7, 2023
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) (RFA-DA-23-056)
Application Receipt Date(s): Multiple dates, see announcement.
Other Funding News
General NIH notices that may be of interest to global health researchers:
Notice of changes to funding opportunities that may be of interest to global health researchers:
Non-NIH funding opportunities that may be of interest to global health researchers:
- The OWSD - Elsevier Foundation Awards for Early Career Women Scientists in the Developing World encourage women working and living in developing countries who are in the early stages of their scientific careers. Awardees must have made a demonstrable impact on the research environment, both at a regional and international level, and must have received their Ph.D. in STEM in the last ten years.
Application deadline: September 15, 2022
- The American Association for Cancer Research has two grants with deadlines in September:
- The German-African Cooperation Projects in Infectiology has an open call for draft proposals of joint research projects between scientists in Germany and Africa focusing on neglected tropical infectious diseases in humans and animals but also research on topics of their social and behavioral aspects.
Proposal deadline: October 26, 2022
Featured News and Information
Fogarty News
NIH News
Training Opportunities
- The Grant Writing Webinar Series for Institutions Building Research and Research Training Capacity is an informational webinar series for faculty and sponsored programs/research development personnel. Attendees will learn considerations for determining research idea and grant writing readiness, selecting opportunities to apply for, effectively writing a grant application, and seeking appropriate feedback.
- Postdoctoral positions at the National Institute of Allergy and Infectious Diseases (NIAID) are now open in the Virus Ecology Unit within the Laboratory of Virology:
Abstract Submission Opportunities
Events
Events for global health researchers:
|
|
|
|
|
|
|
|
The Yale School of Medicine seeks to recruit up to four exceptional
trainees in basic, translational, and/or clinical research each year for
the next five years. YSM Science Fellows will be outstanding recent PhD
graduates with a record of excellence in research, outreach, mentoring,
teaching, and leadership. We seek to recruit, support, retain, and
promote scientists committed to inclusive excellence.
Structured Promotion to Faculty: An innovative cohort-based scientific
development program that will focus on mentorship, career
development, sponsorship, and community building. Fellows will join a
team of collaborating faculty, towards developing an independent
research program. Accepted fellows will establish metrics of success with
their department chairs. Upon achievement, fellows may transition into
a tenure track research position, with an independent and competitive
startup package.
Application Deadline: Sept 1, 2022.
https://apply.interfolio.com/108050
|
|
|
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional). The purpose of the Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control) Funding Opportunity Announcement (FOA) is to build implementation science centers in low- and middle-income countries (LMICs). This initiative will support implementation science research capacity-building activities, including research projects that identify, develop, and test innovative theory-based strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based cancer control interventions in LMICs. Application due date: November 8, 2022.View the CGH list of funding for global cancer research and training.
|
|
New Post Doctoral Fellowship Opportunities!
|
|
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Administrative Supplements to Support Cancer Disparity Collaborative Research Funding Opportunity Reissued
The National Cancer Institute is excited to announce the reissuance of a Funding Opportunity Announcement (FOA) to solicit applications for Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) (the Collaborative), now published as PAR-22-114. We encourage you to share this funding opportunity with your grantees and networks.
Overview
The Collaborative FOA seeks to catalyze and broaden research and collaborations across the Cancer Health Disparities (CHD) spectrum. Key facts about the Collaborative:
- Supports new CHD research among investigators who do not normally conduct it and encourages the partnership of experienced cancer research investigators with CHD-focused researchers.
- Aims to accelerate and strengthen multi-disciplinary CHD research in wide-ranging areas. CHD research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental, and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden, and/or response to treatment in racial/ethnic minorities and/or underserved population groups.
- Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets.
Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a CHD component and possible inclusion of international comparator cohorts. A trans-NCI effort, the reissuance of the Collaborative is supported by NCI’s Division of Cancer Biology, Division of Cancer Treatment and Diagnosis, Division of Cancer Prevention, Division of Cancer Control and Population Sciences, Center to Reduce Cancer Health Disparities (CRCHD), and Center for Global Health.
Applicants are encouraged to access the fact sheet and to apply early to allow adequate time to correct errors found during the submission process.
Key Dates
- Pre-Application Webinar: Program Staff will host a pre-application webinar on Friday, August 5, 2022 from 2:00-3:00 pm Eastern. Register now.
- Due Date: September 6, 2022
- Earliest Start Date: August 2023
Questions
Need more information or have questions? Contact NCI Center to Reduce Cancer Health Disparities Program Director Dr. Maria Jamela (Jay) Revilleza, mariajamela.revilleza@nih.gov.
|
|
The Howard Hughes Medical Institute (HHMI) recently committed 1.5 billion dollars to increase diversity, equity, and inclusion by creating the Freeman Hrabowski Scholars Program. This program is for early-career faculty, including basic researchers and physician-scientists, who have strong potential to become leaders in their fields and advance diversity, equity, and inclusion through their mentorship and understanding of trainees' experiences from races and ethnicities underrepresented in US science.
Dr. Freeman A. Hrabowski III is the outgoing president of the University of Maryland, Baltimore County (UMBC) and is responsible for the Meyerhoff Scholars Program for undergraduate students.
The new HHMI program is accepting applications until September 28, 2022. Details of the program and application instructions are at https://www.hhmi.org/programs/freeman-hrabowski-scholars#Overview. This opportunity may be excellent for some of our CURE/CRCHD ESIs.
|
|
|
|
The summer application period is officially open for research presentations and travel scholarships to the 2022 SACNAS National Diversity in STEM (NDiSTEM) Conference. Attending a conference is a critical component of student's academic and professional development as they navigate their path in STEM. Please take a moment and forward this email to your students to share these opportunities to broaden their networks, access mentorship, and so much more at #2022NDiSTEM!
|
|
Data and Technology Advancement (DATA) National Service Scholar Program: Data Scientists Advancing Biomedical Research
The National Institutes of Health (NIH) Office of Data Science Strategy (ODSS) Data and Technology Advancement (DATA) National Service Scholar Program is seeking experienced data and computer scientists and engineers to tackle challenging biomedical data problems with the potential for substantial public health impact.
Today, biomedical datasets are measured in petabytes and comprise data types ranging from DNA sequences to wearable sensor-generated outputs like heart rate. NIH envisions a biomedical enterprise in which data and information generated in the field, laboratory, and clinic are processed and analyzed in real-time and readily shared. In an increasingly data-rich world, these advances are essential to the NIH mission of enhancing health, lengthening life, and reducing illness and disability.
Achieving this vision requires deep experience in, and knowledge of, data and computer sciences and related fields. To bring talented professionals with this necessary expertise to advance high-impact NIH programs, the ODSS created the DATA National Service Scholar Program. DATA Scholars will substantially optimize and accelerate data science in biomedicine to improve human health and well-being. The program will also encourage transformative approaches that lead to increased efficiency, innovative research, tool development, and analytics.
https://datascience.nih.gov/data-scholars-2022
|
|
|
TENURE-ELIGIBLE PRINCIPAL INVESTIGATOR AND HEALTH DISPARITIES PROGRAM LEADER
The Center for Cancer Research (CCR) at the National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking a world-class tenure-eligible investigator focused on health disparities in cancer to both conduct an independent research program and to lead CCR’s institutional efforts to boldly expand our health disparities research portfolio.
This position is located in the Laboratory of Human Carcinogenesis (LHC) and the candidate will complement the current group of dynamic and collaborative principal investigators (https://ccr.cancer.gov/laboratory-of-human-carcinogenesis#lab-staff-tab-2). The candidate must be an internationally recognized leader in the field of health disparities with demonstrated research productivity in molecular and biological epidemiology with a goal to develop an outstanding independent molecular-based program in health disparities (ideally in lung cancer) at CCR. The successful candidate will be appointed at the level of tenured NIH Senior Investigator, equivalent to Associate/Full Professor in an academic department. The incumbent’s research program will be supported with stable financial resources of the NCI intramural program and full access to a wide range of institutional technology platforms and the NIH Clinical Center.
Applications must be submitted to: https://service.cancer.gov/ccr-careers. Initial review of applications will begin in early June 2022, but applications will be accepted until the position is filled. Applications will be treated as confidential. For more information, contact Lori Holliday, Faculty Recruitment Coordinator at hollidal@mail.nih.gov.
Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis. This position is subject to a background investigation.
|
|
NCI Support for Early-Stage Investigators
 NIH Early-Stage Investigators (ESIs) are defined as having completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as Principal Investigator for a substantial NIH independent research award. Read more about NIH ESI status.
NCI is strongly committed to supporting ESIs and places special emphasis on supporting ESIs with R01 applications. This Fiscal Year 2022, NCI has an ESI R01 payline of the 16th percentile as compared to the established investigator R01 payline of the 11thpercentile. Read more about NCI FY2022 Funding Policy.
Got questions? We’ve got answers! Visit the frequently asked questions page for NIH ESIs. |
|
|
New Find Funding Wizard!
New on the NCI funding for cancer training webpage! A wizard that will help find relevant cancer training funding opportunities based on your career stage.
Check it out and tell your colleagues!
|
|
|
Apply for Extension to NIH Early-Stage Investigator Status
 Are you an NIH Early-Stage Investigator? Has your research been negatively impacted by COVID-19 or other life events? If so, you may be eligible for an extension to your NIH ESI status. Find out how to access the link for requesting an ESI extension.
If you have experienced a lapse in your research or research training or experienced periods of less than full-time effort, you are encouraged to apply for an extension to your ESI status. NIH considers ESI extension requests for COVID-19, medical concerns, disability, family care responsibilities, extended periods of clinical training, natural disasters, and active-duty military service. Extensions are determined on a case-by-case basis at the sole discretion of the NIH. Read here for instructions on how to complete and submit the NIH ESI extension request form. |
|
|
NIH Family Friendly Policies for Extramural Researchers and Trainees
 Family Friendly Policies are integral not only to ensuring we maintain a strong scientific workforce, but also a more diverse one. NIH supports various programs and policies fostering a balanced work and family life from funding available for childcare costs to extensions of ESI status. Learn more about these Family Friendly Initiatives at the NIH All About Grants podcast on NIH Family Friendly Policies. |
|
|
The Population Science Department uses the collective expertise of epidemiologists, biostatisticians, and behavioral scientists to better understand the behavioral, social, environmental, and biologic factors that affect cancer prevention, risk, survivorship, and survival. This research aims to refine personalized risk prediction and targeted intervention strategies, inform public health and clinical decision making for cancer prevention and survivorship, and reduce disparities among medically vulnerable populations. Most of the work within Population Science uses the CancerPrevention Studies (CPS), a series of large- scale prospective cohort studies built and maintained by the American Cancer Society since the 1950’s. The CPS cohorts include extensive survey-based data, other data sources such asaccelerometry, blood, stool, saliva, and tumor tissue. We are particularly interested in, but not limited to, scientists with expertise in the following areas:
- Sleep science
- Cancer Health Disparities
- Breast, endometrial, and ovarian cancer
- Gastrointestinal cancers (e.g. pancreas, colon)
- Molecular epidemiology
- Nutrition, diet patterns, or novel diet assessment
- Cancer survivorship including biologic aging
The scientists hired for these positions will initiate and direct research projects in collaboration with other intramural research scientists and the extramural scientific community that result in published peer- reviewed original research. The scientists will also serve as public spokespeople for Population Science by communicating results of their research to stakeholders-including American Cancer Society staff and volunteers, the scientific community, mainstream media, policy, and the public at large. These full-time positions offer a unique opportunity to contribute to work that has international impact.
Successful candidates should have a sustained focus on cancer epidemiology, will be expected to establish an innovative, independent research portfolio that aligns with the Society’s mission and Population Science researchpriorities, and will contribute to the scientific leadership of the CPS cohorts. Applicants must have a doctoral degree and post-doctoral training in epidemiology, behavioral science, public health, statistics/bioinformatics or a related field,as well as a consistent track-record of publication.
The positions are available immediately, and the salary is commensurate with qualifications and experience. These positions are based at the American Cancer Society’s Research Headquarters in Atlanta, GA. If you are interested, please submit a cover letter that includes a research statement and a curriculum vitae to Dr. Alpa Patel, Senior Vice President, Population Science at alpa.patel@cancer.org.
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing awards of scientists who are outstanding mentors and who have demonstrated compelling commitments and contributions to enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Excellent mentorship and superior training are critical to the development of exceptional future scientists. This administrative supplement recognizes the crucial role great mentors play in the development of future leaders in the scientific research enterprise.
The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.
For more information, visit https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html.
|
|
|
New Funding Opportunity!
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Save the Date: 34th AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
October 26-28, 2022
Barcelona, Spain
The AACR-NCI-EORTC Symposium, commonly referred to as the Triple Meeting, is the premier drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.
For more details, please visit Triple Meeting 2022.
|
|
Fellowship Opportunities
(NEW) NCI Post-doctoral fellowship opportunities
Cancer Research Training Award Fellowship in Health Behaviors Research
As a member of the Health Behaviors Research Branch, the fellow will work collaboratively on various projects to address cancer-related behaviors (e.g., diet and nutrition, physical activity, sleep, alcohol, medication adherence) and associated factors (e.g., genetics, family, environment, culture, policy) to advance behavioral and social science for cancer prevention and control. The program seeks candidates with a Ph.D. or equivalent degree (or highly qualified Ph.D. candidates) with a strong interest in interdisciplinary behavioral and social science research in cancer prevention and control, particularly in behavioral interventions and clinical trials, multilevel and policy research, implementation and health sciences research, and/or cross-disciplinary areas of behavioral science. See the announcement for more details.
--
Postdoctoral Fellowship in Health Equity and Basic Behavioral and Psychological Sciences Research
The Basic Biobehavioral and Psychological Sciences Branch (BBPSB) supports research fundamental to understanding human behaviors, social context, decision-making, and clinical practices associated with cancer etiology, prevention, screening, detection, diagnosis, treatment, and survivorship. Candidates trained in health equity research with a biopsychosocial background are encouraged to apply. Competitive candidates will demonstrate knowledge or interest in using their training to cultivate a health equity and cancer-relevant basic behavioral and psychological sciences research portfolio. See the announcement for more details.
|
|
Fellowship: NCI Cancer Research Training Award
The National Cancer Institute (NCI) Cancer Research Training Award is a full-time position based in Rockville, Maryland that provides opportunities for training and professional development that supports NCI Behavioral Research Program activities and contributes to the scientific literature in tobacco control and related areas of behavioral research. Start dates are January or June 2022, depending on the applicant's graduation date. Applications will be accepted until the position is filled. Please learn more here
|
|
|
Follow us on Facebook and Twitter or click to visit our GMaP R1S website.
|
|
|
|
|
We want to encourage all of our GMaP R1S members to share your research with us via the gmap email address: gmapregion1s@gmail.com, for dissemination throughout our network, so members across the region have the ability to access your recent work.
|
|
|
|
|
|
